• Itraconazole in Candida Biofilm Research: Protocols and Inno

  2026-05-20

  Itraconazole, a triazole antifungal agent, is redefining antifungal assay workflows by leveraging its dual action as a CYP3A4 inhibitor and biofilm disruptor. Integrating recent breakthroughs in PP2A-mediated drug resistance, this guide details practical protocols, troubleshooting, and comparative insights to help researchers overcome persistent Candida challenges.

• Bufuralol Hydrochloride: Precision Tools for Human Intestina

  2026-05-19

  Explore how Bufuralol hydrochloride advances cardiovascular pharmacology research as a non-selective β-adrenergic receptor antagonist, with a novel focus on human iPSC-derived intestinal organoids for translational pharmacokinetic modeling. Gain unique insights beyond conventional protocols and troubleshooting guides.

• ER Stress and Cytokine Storm Drive Pro-Metastatic States in

  2026-05-19

  Conod et al. (2022) reveal that tumor cells surviving impending death acquire prometastatic states through ER stress, nuclear reprogramming, and a cytokine storm. This work uncovers previously uncharacterized cell populations and signaling axes that underlie metastasis initiation, offering new mechanistic targets for therapeutic intervention.

• GCG Disrupts SARS-CoV-2 Nucleocapsid Phase Separation: Mecha

  2026-05-18

  This study reveals that the SARS-CoV-2 nucleocapsid protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process essential for viral replication and assembly. The natural polyphenol GCG, derived from green tea, is shown to inhibit this phase separation and suppress viral replication, providing a mechanistically grounded target for antiviral intervention.

• Coronavirus Macrodomains, PARP Inhibition, and Innate Immuni

  2026-05-18

  Grunewald et al. (2019) demonstrate that the coronavirus macrodomain counters poly(ADP-ribose) polymerase (PARP)-mediated inhibition of viral replication and enhancement of interferon (IFN) production. This study identifies PARP12 and PARP14 as key antiviral effectors, highlighting the macrodomain’s essential role in immune evasion and suggesting new research avenues for host-virus interactions.

• Intestinal TM6SF2 Maintains Gut–Liver Axis to Prevent MASH

  2026-05-17

  This study demonstrates that intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and regulating host–microbiota interactions. The findings reveal a mechanistic link between intestinal lipid handling, lysophosphatidic acid (LPA) signaling, and liver inflammation, suggesting new avenues for therapeutic intervention.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-05-16

  Satir et al. (2020) provide evidence that partial inhibition of BACE1, leading to up to 50% reduction in amyloid-β (Aβ) production, does not impair synaptic transmission in primary cortical neurons. These findings inform dosing paradigms for BACE1 inhibitors in Alzheimer's disease research, supporting moderate target engagement to avoid functional side effects.

• Clarithromycin as a CYP3A Inhibitor: Advanced Insights for C

  2026-05-15

  Explore how Clarithromycin, a potent CYP3A inhibitor, enables sophisticated investigation of drug-drug interactions and metabolism in cardiovascular and pharmacokinetic research. This article offers unique, evidence-based protocols and comparative analysis for advanced experimental design.

• RG108 DNA Methyltransferase Inhibitor: Applied Cancer Resear

  2026-05-15

  RG108 stands out as a non-nucleosidic DNA methyltransferase inhibitor that enables targeted epigenetic modulation without covalent enzyme trapping. This article explores optimized experimental workflows, practical troubleshooting, and the latest comparative insights, empowering cancer researchers to reactivate silenced genes with confidence.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-05-14

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) delivers defined, visible molecular weight standards for SDS-PAGE and Western blot workflows that require straightforward protein size verification and transfer QC. It is not suitable for applications demanding native protein conditions, direct protein quantification, or when EDTA is required.

• α2-Adrenergic Modulation of Cholinergic Airway Tone in Horse

  2026-05-14

  This study elucidates how α2-adrenergic receptor stimulation, via agents like clonidine or xylazine, selectively inhibits cholinergic nerve-mediated airway contractions in equine distal bronchi. The antagonist Tolazoline reverses this effect, highlighting presynaptic modulation as a therapeutic target for airway obstruction.

• Baicalin Restores Adult Visual Cortex Plasticity in Amblyopi

  2026-05-13

  This study demonstrates that baicalin, a flavone glycoside from Scutellaria baicalensis, can reactivate ocular dominance plasticity and restore visual function in adult mice with amblyopia. The findings establish a mechanistic link between baicalin-mediated cortical disinhibition and functional recovery, with implications for developing new therapies targeting neuroplasticity in adult vision disorders.

• Lipo3K Transfection Reagent: Efficient Delivery for Challeng

  2026-05-13

  Lipo3K Transfection Reagent unlocks high-efficiency gene delivery, even in difficult-to-transfect cells, with minimal cytotoxicity and workflow simplicity. Integrated enhancements enable robust DNA, siRNA, and co-transfection—empowering advanced gene expression and RNA interference studies while streamlining post-transfection handling.

• Fluorescein Tyramide: Signal Amplification in IHC & ISH

  2026-05-12

  Fluorescein Tyramide is a high-sensitivity fluorescent labeling dye enabling robust signal amplification in immunohistochemistry and in situ hybridization. Its performance is validated in low-abundance target detection and is essential for workflows demanding enhanced fluorescent signal clarity.

• Redefining Apoptotic Pathways: TNF-alpha in Translational Re

  2026-05-12

  This thought-leadership article unpacks how recent advances in cell death signaling—particularly the discovery that RNA Pol II inhibition triggers apoptosis independent of transcriptional loss—redefine the strategic deployment of TNF-alpha recombinant murine protein in translational models. It integrates mechanistic insight, experimental guidance, and competitive context, culminating in a forward-looking vision for researchers seeking to harness apoptosis and immune modulation in disease modeling and therapeutic innovation.

458 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page